These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38474611)
1. Novel Scaffold Agonists of the α Sun S; Li P; Wang J; Zhao D; Yang T; Zhou P; Su R; Zheng Z; Li S Molecules; 2024 Feb; 29(5):. PubMed ID: 38474611 [TBL] [Abstract][Full Text] [Related]
2. The Discovery of Novel α Zhou P; Lu F; Zhu H; Shi B; Wang X; Sun S; Li Y; Su R Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000340 [TBL] [Abstract][Full Text] [Related]
3. The α Kitano T; Kobayashi T; Yamaguchi S; Otsuguro K J Vet Pharmacol Ther; 2019 Mar; 42(2):243-247. PubMed ID: 30417462 [TBL] [Abstract][Full Text] [Related]
4. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors. Chabot-Doré AJ; Millecamps M; Naso L; Devost D; Trieu P; Piltonen M; Diatchenko L; Fairbanks CA; Wilcox GL; Hébert TE; Stone LS Neuropharmacology; 2015 Dec; 99():285-300. PubMed ID: 26254859 [TBL] [Abstract][Full Text] [Related]
5. The presence of beta2-adrenoceptors sensitizes alpha2A-adrenoceptors to desensitization after chronic epinephrine treatment. Bawa-Khalfe T; Altememi GF; Mandyam CD; Schwarz LA; Eikenburg DC; Standifer KM BMC Pharmacol; 2007 Dec; 7():16. PubMed ID: 18096057 [TBL] [Abstract][Full Text] [Related]
6. Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor. Li Z; Li J; Liu L; Deng W; Liu Q; Liu R; Zhang W; He Z; Fan L; Yang Y; Duan Y; Hou H; Wang X; Yang Z; Wang X; Chen S; Wang Y; Huang N; Chen J Drug Des Devel Ther; 2020; 14():2585-2594. PubMed ID: 32694911 [TBL] [Abstract][Full Text] [Related]
8. High throughput screening and structure-activity relationship study of potential α2A-adrenoceptor agonists by LANCETM cAMP assay. Yang H; He L; Yan M; He JG; Yu T Comb Chem High Throughput Screen; 2013 Jun; 16(7):522-30. PubMed ID: 23514320 [TBL] [Abstract][Full Text] [Related]
9. Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic Receptors. Fragola NR; Brems BM; Mukherjee M; Cui M; Booth RG ACS Chem Neurosci; 2023 May; 14(10):1884-1895. PubMed ID: 37104867 [TBL] [Abstract][Full Text] [Related]
10. Alpha 2-adrenergic agonist enrichment of spinophilin at the cell surface involves beta gamma subunits of Gi proteins and is preferentially induced by the alpha 2A-subtype. Brady AE; Wang Q; Allen PB; Rizzo M; Greengard P; Limbird LE Mol Pharmacol; 2005 May; 67(5):1690-6. PubMed ID: 15705742 [TBL] [Abstract][Full Text] [Related]
11. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors. Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005 [TBL] [Abstract][Full Text] [Related]
12. The anticonvulsant and proconvulsant effects of alpha2-adrenoreceptor agonists are mediated by distinct populations of alpha2A-adrenoreceptors. Szot P; Lester M; Laughlin ML; Palmiter RD; Liles LC; Weinshenker D Neuroscience; 2004; 126(3):795-803. PubMed ID: 15183527 [TBL] [Abstract][Full Text] [Related]
13. Suppression of P2X3 receptor-mediated currents by the activation of α Hao JW; Qiao WL; Li Q; Wei S; Liu TT; Qiu CY; Hu WP CNS Neurosci Ther; 2022 Feb; 28(2):289-297. PubMed ID: 34862748 [TBL] [Abstract][Full Text] [Related]
15. Designing Chromane Derivatives as α Lv X; Zhou P; Qiao X; Li Y; Yang X; Wang J; He X; Su R J Med Chem; 2024 Jul; 67(13):11435-11449. PubMed ID: 38889119 [TBL] [Abstract][Full Text] [Related]
16. Enhanced hypotensive, bradycardic, and hypnotic responses to alpha2-adrenergic agonists in spinophilin-null mice are accompanied by increased G protein coupling to the alpha2A-adrenergic receptor. Lu R; Chen Y; Cottingham C; Peng N; Jiao K; Limbird LE; Wyss JM; Wang Q Mol Pharmacol; 2010 Aug; 78(2):279-86. PubMed ID: 20430865 [TBL] [Abstract][Full Text] [Related]
17. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304. Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629 [TBL] [Abstract][Full Text] [Related]
18. Azi-medetomidine: Synthesis and Characterization of a Novel α2 Adrenergic Photoaffinity Ligand. McKinstry-Wu AR; Woll KA; Joseph TT; Bu W; White ER; Bhanu NV; Garcia BA; Brannigan G; Dailey WP; Eckenhoff RG ACS Chem Neurosci; 2019 Nov; 10(11):4716-4728. PubMed ID: 31638765 [TBL] [Abstract][Full Text] [Related]
19. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes. Renouard A; Widdowson PS; Millan MJ J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207 [TBL] [Abstract][Full Text] [Related]